207 related articles for article (PubMed ID: 33477348)
41. Feasibility of Cowpea chlorotic mottle virus-like particles as scaffold for epitope presentations.
Hassani-Mehraban A; Creutzburg S; van Heereveld L; Kormelink R
BMC Biotechnol; 2015 Aug; 15():80. PubMed ID: 26311254
[TBL] [Abstract][Full Text] [Related]
42. Chimeric RHDV Virus-Like Particles Displaying Foot-and-Mouth Disease Virus Epitopes Elicit Neutralizing Antibodies and Confer Partial Protection in Pigs.
Rangel G; Bárcena J; Moreno N; Mata CP; Castón JR; Alejo A; Blanco E
Vaccines (Basel); 2021 May; 9(5):. PubMed ID: 34066934
[TBL] [Abstract][Full Text] [Related]
43. Plant-Produced Antigen Displaying Virus-Like Particles Evokes Potent Antibody Responses against West Nile Virus in Mice.
He J; Lai H; Esqueda A; Chen Q
Vaccines (Basel); 2021 Jan; 9(1):. PubMed ID: 33477363
[TBL] [Abstract][Full Text] [Related]
44. Activation of a heterogeneous hepatitis B (HB) core and e antigen-specific CD4+ T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection.
Jung MC; Diepolder HM; Spengler U; Wierenga EA; Zachoval R; Hoffmann RM; Eichenlaub D; Frösner G; Will H; Pape GR
J Virol; 1995 Jun; 69(6):3358-68. PubMed ID: 7538172
[TBL] [Abstract][Full Text] [Related]
45. Design of hepadnavirus core protein-based chimeric virus-like particles carrying epitopes from respiratory syncytial virus.
Shao S; Zhang XF; Hou JW; Yang SS; Han ZB; Wu HL; Tang F; Li XY; Lei ZH; Zhao ZX; Li SX; Liu ZM; Shan P; Jin YQ; Su JG; Liang Y; Zhang J; Li QM
NPJ Vaccines; 2024 Mar; 9(1):62. PubMed ID: 38503757
[TBL] [Abstract][Full Text] [Related]
46. [Exposure of the major immunodominant epitope of the gp51 envelope protein of bovine leukosis virus on the surface of the hepatitis B core antigen capsid].
Ul'rikh R; Borisova GP; Siakkou Kh; Plattser K; Ose VP; Berzin' IG; Dreĭlinia DE; Pushko PM; Tsibinogin VV; Pumpen PP
Mol Biol (Mosk); 1991; 25(2):368-74. PubMed ID: 1715509
[TBL] [Abstract][Full Text] [Related]
47. Expression and characterization of hepatitis E virus-like particles and non-virus-like particles from insect cells.
Qi Y; Fan J; Huang W; Zhao C; Wang Y; Kong FT; Kong W; Jiang C
Biotechnol Appl Biochem; 2016 May; 63(3):362-70. PubMed ID: 25824972
[TBL] [Abstract][Full Text] [Related]
48. An N-terminal extension to the hepatitis B virus core protein forms a poorly ordered trimeric spike in assembled virus-like particles.
McGonigle R; Yap WB; Ong ST; Gatherer D; Bakker SE; Tan WS; Bhella D
J Struct Biol; 2015 Feb; 189(2):73-80. PubMed ID: 25557498
[TBL] [Abstract][Full Text] [Related]
49. Chimeric virus-like particles for the delivery of an inserted conserved influenza A-specific CTL epitope.
Cheong WS; Reiseger J; Turner SJ; Boyd R; Netter HJ
Antiviral Res; 2009 Feb; 81(2):113-22. PubMed ID: 19007818
[TBL] [Abstract][Full Text] [Related]
50. Hepatitis B virus-like particles expressing Plasmodium falciparum epitopes induce complement-fixing antibodies against the circumsporozoite protein.
Kingston NJ; Kurtovic L; Walsh R; Joe C; Lovrecz G; Locarnini S; Beeson JG; Netter HJ
Vaccine; 2019 Mar; 37(12):1674-1684. PubMed ID: 30773400
[TBL] [Abstract][Full Text] [Related]
51. Chimeric hepatitis B virus core particles carrying an epitope of anthrax protective antigen induce protective immunity against Bacillus anthracis.
Yin Y; Zhang J; Dong D; Liu S; Guo Q; Song X; Li G; Fu L; Xu J; Chen W
Vaccine; 2008 Oct; 26(46):5814-21. PubMed ID: 18786589
[TBL] [Abstract][Full Text] [Related]
52. Rapid, high-level production of hepatitis B core antigen in plant leaf and its immunogenicity in mice.
Huang Z; Santi L; LePore K; Kilbourne J; Arntzen CJ; Mason HS
Vaccine; 2006 Mar; 24(14):2506-13. PubMed ID: 16417953
[TBL] [Abstract][Full Text] [Related]
53. Plant-expressed Hepatitis B core antigen virus-like particles: Characterization and investigation of their stability in simulated and pig gastro-intestinal fluids.
Berardi A; Lomonossoff GP; Evans DJ; Barker SA
Int J Pharm; 2017 Apr; 522(1-2):147-156. PubMed ID: 28263835
[TBL] [Abstract][Full Text] [Related]
54. Selection of a peptide mimicking neutralization epitope of hepatitis E virus with phage peptide display technology.
Gu Y; Zhang J; Wang YB; Li SW; Yang HJ; Luo WX; Xia NS
World J Gastroenterol; 2004 Jun; 10(11):1583-8. PubMed ID: 15162530
[TBL] [Abstract][Full Text] [Related]
55. Internal core protein cleavage leaves the hepatitis B virus capsid intact and enhances its capacity for surface display of heterologous whole chain proteins.
Walker A; Skamel C; Vorreiter J; Nassal M
J Biol Chem; 2008 Nov; 283(48):33508-15. PubMed ID: 18826949
[TBL] [Abstract][Full Text] [Related]
56. Plant-based chimeric HPV-virus-like particles bearing amyloid-β epitopes elicit antibodies able to recognize amyloid plaques in APP-tg mouse and Alzheimer's disease brains.
Gonzalez-Castro R; Acero Galindo G; García Salcedo Y; Uribe Campero L; Vazquez Perez V; Carrillo-Tripp M; Gevorkian G; Gomez Lim MA
Inflammopharmacology; 2018 Jun; 26(3):817-827. PubMed ID: 29094307
[TBL] [Abstract][Full Text] [Related]
57. Virus-like particles displaying envelope domain III of dengue virus type 2 induce virus-specific antibody response in mice.
Arora U; Tyagi P; Swaminathan S; Khanna N
Vaccine; 2013 Jan; 31(6):873-8. PubMed ID: 23261049
[TBL] [Abstract][Full Text] [Related]
58. Bacteria expressed hepatitis E virus capsid proteins maintain virion-like epitopes.
Wei M; Zhang X; Yu H; Tang ZM; Wang K; Li Z; Zheng Z; Li S; Zhang J; Xia N; Zhao Q
Vaccine; 2014 May; 32(24):2859-65. PubMed ID: 24662711
[TBL] [Abstract][Full Text] [Related]
59. Artificially designed hepatitis B virus core particles composed of multiple epitopes of type A and O foot-and-mouth disease virus as a bivalent vaccine candidate.
Lei Y; Shao J; Zhao F; Li Y; Lei C; Ma F; Chang H; Zhang Y
J Med Virol; 2019 Dec; 91(12):2142-2152. PubMed ID: 31347713
[TBL] [Abstract][Full Text] [Related]
60. Characterization of Three Novel Linear Neutralizing B-Cell Epitopes in the Capsid Protein of Swine Hepatitis E Virus.
Chen Y; Liu B; Sun Y; Li H; Du T; Nan Y; Hiscox JA; Zhou EM; Zhao Q
J Virol; 2018 Jul; 92(13):. PubMed ID: 29669835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
